Skip to main content


  1. Sandin J., Nylander I., Georgieva J., Schött P.A., Ögren S.O. and Terenius L. The effect of 
Dynorphin B on spatial learning and memory when microinjected into the hippocampus of 
the rat. Analgesia, 1 (4-6), 691-694 (1995). 

  2. Ögren S.O., Kehr J. and Schött P.A. Effects of ventral hippocampal galanin on spatial 
learning and on in vivo acetylcholine release in the rat. Neuroscience, 75 (4), 1127-1140 

  3. Sandin J., Georgieva J., Schött P.A., Ögren S.O and Terenius L. Nociceptin/Orphanin FQ 
microinjected into hippocampus impairs spatial learning in rats. European Journal of Neuroscience, 9 (1), 194-197 (1997). 

  4. Schött P.A., Bjelke B. and Ögren S.O. Distribution and kinetics of galanin infused into the 
ventral hippocampus. Relationship to spatial learning. Neuroscience, 83 (1), 123-136 (1998). 

  5. Sandin J., Nylander I., Georgieva J., Schött P.A., Ögren S.O. and Terenius L. Dynorphin B 
impairs spatial learning in rats: A κ-opioid receptor mediated effect. Neurosciene, 85 (2), 375- 
382 (1998). 

  6. Ögren S.O., Schött P.A., Kehr J., Yoshitake T., Misane I., Mannström P. and Sandin J. 
Modulation of acetylcholine and serotonin transmission by galanin: relationship to spatial 
and aversive learning. Annals ofthe New York Academy ofSciences, 863, 342-363 (1998). 

  7. Schött P.A., Bjelke B. and Ögren S.O. Time-dependent effects of intrahippocampal galanin 
on spatial learning. Relationship to distribution and kinetics. Annals ofthe New York Academy of Sciences, 863, 454-456 (1998). 

  8. Åhlander M., Misane I., Schött P.A. and Ögren S.O. A behavioural analysis of the spatial 
learning deficit induced by the NMDA receptor antagonist MK-801 (Dizolcipine) in the rat. 
Neuropsychopharmacology, 21 (3), 414-426 (1999). 

  9. Ögren S.O., Schött P.A., Kehr J., Misane I. and Razani H. Galanin and learning. Brain Research, 848 (1-2), 174-182 (1999). 

  10. Jansson A., Tinner B., Razani H., Wang F.-H., Schött P.A., Agnati L.F., Ögren S.O. and 
Fuxe K. Internalization of intracerebrally administered porcine galanin (1-29) by a discrete nerve cell population in the hippocampus of the rat. Experimental Neurology, 161 (1), 153-166 (2000). 

  11. Schött P.A., Hökfelt T. and Ögren S.O. Galanin and spatial learning in the rat. Evidence for a differential role for galanin in subregions of the hippocampal formation. Neuropharmacology, 39 (8), 1386-1403 (2000).
  12. Schött P.A. Hippocampal galanin and acetylcholine in spatial learning. Academic thesis, ISBN: 91-628-4137-8, Repro Print AB, Stockholm, published 2000-05-19 (Thesis). 

  13. Åhlander Lüttgen M., Madjid N., Schött P.A., Sandin J. and Ögren S.O. Analysis of the role of the 5-HT1B receptor in spatial and aversive learning in the rat. Neuropsychopharmacology, 28, 1642-1655 (2003). 

  14. Elvander E., Schött P.A., Sandin J., Bjelke B., Kehr J., Yoshitake T. and Ögren S.O. Intraseptal muscarinic ligands and galanin: Influence on hippocampal acetylcholine and cognition. Neuroscience, 126 (3), 541-547 (2004). 

  15. Georgievska B., Sandin J., Doherty J., Mörtberg A., Neelissen J., Andersson A., Gruber S., Nilsson Y., Schött P., Arvidsson P.I., Hellberg S., Osswald G., Berg S., Fälting J. and Bhat R.V. AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans. Journal of Neurochemistry, 125 (3), 446-456 (2013).
  16. Varnäs K., Juréus A., Johnström P., Ahlgren C., Schött P., Schou M., Gruber S., Jerning E., Malmborg J., Halldin C., Afzelius L., and Farde L. Integrated strategy for use of positron emission tomography in nonhuman primates to confirm multitarget occupancy of novel psychotropic drugs: An example with AZD3676. Journal of Pharmacology and Experimental Therapeutics, 358 (3), 464-471 (2016).